Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Amgen Inc. (NASDAQ:AMGN) is one of the 10 Most Profitable S&P 500 Stocks to Buy Now. On March 19, 2026, Wells Fargo raised ...

Amgen stock holds above key SMAs as strong drug sales, biosimilars, and MariTide pipeline momentum offset looming patent ...

Chicago, IL – February 5, 2026 – Today, Zacks Investment Ideas feature highlights Amgen AMGN, Apple AAPL and Microsoft MSFT. Amgen Stock Hits 52-Week High: A Buy Signal? Amgen is having a moment. The ...

Amgen (NASDAQ:AMGN) is preparing to release its quarterly earnings on Tuesday, 2026-02-03. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect Amgen ...

Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want? One thing's for sure: You'll never discover truly ...

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for ...

In this article, we will look at the 10 Most Profitable S&P 500 Stocks to Buy Now. Profitability has moved back to the center ...